Skip to main content

Table 3 Design and aims of the selected studies

From: A systematic review of adult admissions to ICUs related to adverse drug events

Study

Country

Study duration

Study design

Type of hospital

Type of ICU

Number of patients admitted during studied period

Aims of the study

Trunet and colleagues, 1986 [10]

France

33 months (August 1978 to April 1981)

Prospective monocentre

Teaching hospital

Multidisciplinary ICU

1,651

Determine cause and effect relationship between drugs and adverse event, severity of DII, role of underlying disease and potential preventability of DII

IGICE, 1987 [11]

Italy

6 months

Prospective (data collection on a given day each week)

ND

27 general ICUs

4,537

Document aspects of ADR epidemiology in 27 general ICUs

Nelson and Talbert, 1996 [12]

USA

1 month (July to August 1993)

Prospective monocentre

Teaching hospital

Medical ICU, CCU and internal medicine service

127a

Describe the frequency and pattern of drug-related morbidity that results in hospital admission and the extent to which these admissions are avoidable

Darchy and colleagues, 1999 [13]

France

12 months (January to December 1994)

Retrospective monocentre

General hospital (500 beds)

Medico-surgical ICU (15 beds), CCU (6 beds)

623

Determine whether aging of the general population and medical advances have altered the incidence, causes and consequences of severe IDs, compared with Trunet and colleagues first study [21]

Hammerman and Kapeliovich, 2000 [14]

Israel

36 months (July 1994 to June 1997)

Prospective monocentre

Teaching hospital (900 beds)

CCU (9 beds)

2,559

Evaluate major cardiac iatrogenic disease as the cause of admission to the CCU

Lehmann and colleagues, 2005 [15]

USA

12 months (November 1998 to November 1999)

Prospective monocentre

Four teaching hospitals

Four surgical ICUs, three medical ICUs and one paediatric ICU

5,727

Identify the frequency and type of iatrogenic medical events requiring admission to the ICU. Assess the consequences of iatrogenic medical events for patients, and the incidence of disclosure of iatrogenic medical events to patients

Grenouillet-Delacre and colleagues, 2007 [16]

France

6 months (May to October 2003)

Prospective monocentre

Teaching hospital

Medical ICU

436

Assess the characteristics of life-threatening ADR in patients admitted to a medical ICU in order to identify associated risk factors that could facilitate early identification

Rivkin, 2007 [17]

USA

19 weeks (December 2004 to May 2005)

Prospective monocentre

Teaching hospital (1,076 beds)

Medical ICU (12 beds)

281

Determine frequency, severity and preventability of ADR leading to admission to a medical ICU

Schwake and colleagues, 2009 [18]

Germany

12 months (January to December 2003)

Prospective monocentre

Teaching hospital (1,685 beds)

Medical ICU (14 beds)

1,554

Determine the incidence of ICU admissions due to ADR and compare affected patients with patients admitted to the ICU for the treatment of deliberate self-poisoning using medical drugs

Mercier and colleagues, 2010 [19]

France

6 months (November 1999 to April 2000)

Prospective monocentre

Teaching hospital

Medical ICU (27 beds)

528

Determine the incidence, risk factors, severity and preventability of IEs as cause of ICU admission

Nazer and colleagues, 2013 [20]

Jordan

5 months (August to December 2010)

Prospective monocentre

Teaching cancer centre (170 beds)

Medico-surgical ICU (12 beds)

249

Describe the incidence, characteristics and cost of ADE that necessitate admission to the ICU in oncology patients

  1. ADE, adverse drug events; ADR, adverse drug reactions; CCU, coronary care unit; DII, drug-induced illness; ID, iatrogenic disease; IE, iatrogenic event; IGICE, Italian Group on Intensive Care Evaluation; ND, not documented. aNumber of patients hospitalised in the medical ICU department.